Michiel Vermeulen - Biography#

Michiel Vermeulen performed his doctoral work in the laboratory of Henk Stunnenberg at the Radboud University Nijmegen in the Netherlands, where he mainly focused on the functional characterization of transcriptional co-repressor complexes. In 2005 he moved to Munich to join the lab of Matthias Mann. There, he pioneered the application of quantitative mass spectrometry technology to identify proteins that specifically interact with post-translational modifications on core histones. In 2009 he was appointed as assistant professor and in 2013 as associate professor at the University Medical Center Utrecht in The Netherlands, where he continued to use quantitative mass-spectrometry to study proteins that interact with chromatin (so-called chromatin readers). In 2014 he was appointed full professor at the Radboud University Nijmegen, where his main research focus is to apply integrative omics approaches to study gene expression regulation in development and disease. His ground-breaking work during the last decade in the research area of gene expression regulation in health and disease has resulted in a large number of high impact publications and invitations to speak at international conferences. The pioneering technology developed by the Vermeulen lab is greatly appreciated by the scientific community, as evidenced by a large number of high impact collaborative papers with leading international scientists. He was awarded a prestigious ERC Starting Grant in 2012 and an ERC Consolidator Grant in 2017. He (co)-authored 97 publications, many of these in high impact journals. In 2017, Michiel Vermeulen was elected as one of the 43 founding members of the Oncode Institute, a prestigious new virtual institute dedicated to fundamental cancer research (www.oncode.nl). His international team of researchers currently consists of 6 PhD students, 6 post-docs, two technician and a number of bachelor and master students.